A Board Earns the Right to Defend Its Strategy by Challenging It First

An activist asking for a board seat does not automatically mean the board has failed. It does mean the board’s case is about to be tested. 

When a significant shareholder concludes that engagement from outside the boardroom is no longer enough, the governance question becomes more interesting than the corporate drama. 

Why does the investor believe representation inside the boardroom is necessary? 

Perhaps the disagreement concerns strategy. 

It may be capital allocation, portfolio complexity, board composition, leadership, succession or the pace of change. 

Sometimes the activist’s thesis will be compelling. On other occasions, directors may reasonably conclude that it prioritises short-term value over the company’s longer-term interests. 

A board seat demand is therefore not proof that the activist is right or that directors are wrong. 

However, it is often a powerful governance stress test. 

The board must demonstrate that it understands the criticism, has examined the alternatives and can explain why its chosen path remains in the interests of shareholders as a whole. 

That matters because shareholder activism is becoming harder for boards to dismiss as an occasional feature of US capital markets. 

The Lazard Review of Shareholder Activism for H1 2026 recorded 184 new activist campaigns globally during the first six months of 2026, making it the busiest six-month period on record. Although European activity moderated overall, the UK accounted for 57% of European campaigns. Board change featured in 35% of global campaigns, while capital-allocation demands appeared in 39% and strategy-related demands in 23%. 

Those numbers deserve board attention. 

They suggest activism is increasingly focused not merely on performance, but on how boards exercise judgement about strategy, capital and corporate structure. 

The important question is therefore not: 

How do we stop an activist? 

It is: 

What would an activist identify about our company that the board has not already challenged itself on? 

That is where preparedness becomes governance rather than defence. 

Read More: Corporate Governance Support 

Executive Takeaway 

A demand for board representation should prompt directors to test several areas immediately: 

• Whether strategy is clear and credible 

• Whether capital allocation has been explained convincingly 

• Whether the board has examined credible strategic alternatives 

• Whether board composition matches the company’s current challenges 

• Whether shareholder engagement has produced genuine understanding 

• Whether investor concerns have reached the whole board rather than remaining with management 

• Whether performance gaps are being explained rather than rationalised 

• Whether the board can show how major decisions were challenged 

• Whether succession and refreshment remain credible 

• Whether governance reporting explains outcomes rather than process 

The underlying principle is simple. 

Activism often gains momentum where investors believe the board has stopped asking a question they still consider unresolved. 

A strong board should discover that question before somebody else turns it into a campaign. 

Shareholder activism is increasingly a board-level governance issue 

Activism has moved closer to mainstream stewardship. 

The Lazard Annual Review of Shareholder Activism 2025 recorded 297 campaigns during 2025, the third consecutive record year globally. Board change appeared in 37% of campaigns, while capital-allocation demands rose to 31%, well above recent historical levels. 

Activity accelerated further during the first half of 2026. 

Meanwhile, the Skadden and Mergermarket Activist Investing in Europe 2026 study found European companies facing increasingly assertive engagement from investors, including more public letters, media activity and board-focused demands. Its research also found underwhelming shareholder returns and perceived gaps in board expertise among important reasons investors seek leadership or board changes. 

This does not mean boards should accept activist arguments automatically. 

Activists have their own investment horizons, incentives and theses. Directors remain responsible for exercising independent judgement in the interests of the company rather than implementing whichever proposal is presented most forcefully. 

Yet dismissiveness carries its own risk. 

An activist may be saying publicly what other shareholders have been discussing privately. 

By the time a board seat becomes the issue, the deeper disagreement may have existed for considerably longer. 

1. The first question is not whether the activist is right. It is whether the board understands why the argument resonates 

Boards can lose valuable time by treating activism primarily as an adversarial event. 

Lawyers are appointed. 

Advisers prepare defence materials. 

Investor-relations programmes intensify. 

The organisation begins analysing the activist. 

Some of that may be necessary. 

However, the stronger board also analyses itself. 

Why could this argument attract support? 

What evidence might investors find persuasive? 

Which parts of the company’s strategy are difficult to explain? 

Where has performance diverged from expectations? 

Which assumptions has the board relied upon? 

Have those assumptions been revisited? 

A serious governance response separates three questions: 

Is the activist’s diagnosis accurate? 

The board should test the evidence objectively. 

Is the activist’s proposed solution credible? 

A correct diagnosis does not guarantee the right remedy. 

Can the board explain why its alternative is better? 

Directors ultimately need a proposition that shareholders can understand. 

That final question is frequently underestimated. 

A board may possess a sophisticated internal strategy yet struggle to communicate why that strategy creates more value than the alternatives. 

When that happens, the gap between internal conviction and external understanding becomes a governance vulnerability. 

2. Capital allocation is increasingly where strategy becomes measurable 

Capital allocation sounds financial. 

In reality, it is one of the clearest expressions of board judgement. 

Where a company invests reveals what management and directors genuinely believe about: 

• Growth 

• Risk 

• Returns 

• Competitive advantage 

• Acquisitions 

• Divestments 

• Debt 

• Buybacks 

• Dividends 

• Portfolio structure 

This helps explain why capital allocation has become such a prominent activist theme. 

According to Lazard’s H1 2026 analysis, capital-allocation demands appeared in 39% of campaigns, compared with a historical level of 23%. 

Boards should pay attention to the implication. 

Investors increasingly want more than an explanation of where capital is going. 

They want to understand why that use of capital is superior to realistic alternatives. 

A board should therefore be prepared to explain: 

• Why capital remains invested in each material business 

• Which return thresholds apply 

• How acquisitions are evaluated 

• When divestment becomes appropriate 

• Why cash is retained 

• How leverage is determined 

• When buybacks create value 

• Why particular strategic investments deserve priority 

• How management performance against previous capital decisions is assessed 

Capital allocation becomes vulnerable when it is defended through habit. 

We have always owned this business. 

We have historically reinvested at this level. 

This structure has worked before. 

None of those statements proves that today’s allocation remains rational. 

Good governance requires capital to compete for its place continually. 

3. A board should know the case against its own strategy 

Strategy reviews often ask management to explain the preferred plan. 

That is necessary but insufficient. 

A strong board should also understand the best argument against that plan. 

What would happen if the company: 

• Divested a business? 

• Reduced investment? 

• Accelerated investment? 

• Sold an asset? 

• Changed market? 

• Separated divisions? 

• Returned additional capital? 

• Acquired rather than built? 

• Simplified the structure? 

• Chose a different growth model? 

Directors do not need to pursue every alternative. 

They should know why they rejected credible ones. 

This becomes particularly important when performance disappoints. 

A strategy that appeared reasonable three years ago cannot be protected simply because changing direction would imply the original assumptions were wrong. 

Boards need the institutional confidence to revise their own decisions. 

That is not weakness. 

It is governance doing its job. 

4. Strategic conviction needs evidence, not repetition 

One of the least convincing responses to external challenge is simply restating the existing strategy. 

A strategy may be sound. 

Repeating it does not demonstrate that. 

The board needs to show that the strategy has survived challenge. 

That requires evidence around: 

• Performance against original assumptions 

• Returns on invested capital 

• Competitive position 

• Customer behaviour 

• Operating performance 

• Execution milestones 

• Market changes 

• Risk 

• Strategic alternatives 

• Capital requirements 

External conditions may also have changed since the plan was approved. 

Interest rates move. 

Regulation changes. 

Competitors improve. 

Technology disrupts assumptions. 

Consumer behaviour shifts. 

The board therefore needs a living strategic thesis rather than a historic strategic commitment. 

Strong boards are committed to the company’s success, not emotionally committed to a particular strategy. 

5. Shareholder engagement should function as an early-warning system 

The FRC Corporate Governance Code Guidance states that an effective board should appreciate the importance of dialogue with shareholders and use that dialogue to inform decision making. It also gives the Chair an important role in developing constructive relationships with major shareholders and ensuring their views reach the board. 

That is more demanding than investor relations. 

Good engagement should allow directors to understand: 

• What investors support 

• Where confidence is weakening 

• Which assumptions are questioned 

• Whether valuation concerns are structural 

• Which governance issues repeatedly arise 

• Whether shareholders understand the strategy 

• What investors believe management is overlooking 

The objective is not to govern by shareholder opinion poll. 

Boards must retain independent judgement. 

However, investor disagreement becomes more dangerous when directors misunderstand its depth. 

A shareholder meeting once a year is therefore not enough for companies with concentrated ownership or significant investor concern. 

Year-round dialogue can provide valuable early warning. 

PwC’s analysis of the 2026 proxy season similarly argues that boards should use shareholder engagement as an early-warning mechanism and regularly pressure-test strategy, performance, capital allocation and governance vulnerabilities. 

That advice travels well across markets. 

6. The Chair should know what investors are saying before the activist letter arrives 

Investor relations teams often possess detailed knowledge of shareholder sentiment. 

The governance risk appears when that information does not reach the board accurately. 

Management may hear criticism as frustration. 

Investors may intend it as an escalating warning. 

The Chair and senior independent director therefore need independent visibility over significant shareholder concerns. 

Questions worth asking include: 

• Which investors are becoming less supportive? 

• What criticism appears repeatedly? 

• Has the same concern persisted across several meetings? 

• Are shareholders questioning management credibility? 

• Does the issue concern execution or the strategy itself? 

• Are investors questioning board composition? 

• Which shareholders might support an alternative proposal? 

The board does not need a verbatim account of every investor conversation. 

It does need enough information to understand changes in confidence. 

Poor information flow can turn a manageable disagreement into a public governance contest. 

Read More: Board & Shareholder Meetings 

7. A board seat demand is ultimately a challenge to representation and judgement 

When an investor asks for representation, the issue is not merely another chair around the table. 

The request implicitly raises a deeper question: 

Does the existing board contain the perspectives required to evaluate the company’s current position? 

The answer may be yes. 

A board should not add directors simply because an activist asks. 

However, directors should examine their composition with genuine objectivity. 

The Skadden 2026 European activism study found respondents frequently associating board-change demands with concerns about shareholder returns and perceived gaps in specific expertise. 

That makes board skills a strategic issue. 

Boards should ask whether they possess sufficient experience in areas such as: 

• Capital allocation 

• M&A 

• Restructuring 

• International growth 

• Technology 

• Artificial intelligence 

• Sector disruption 

• Operational transformation 

• Regulation 

• Investor engagement 

The correct question is not whether every director is individually excellent. 

It is whether the board collectively contains what the company now needs. 

Those are different tests. 

Explore More: Board Skills Audit 

8. Board refreshment becomes harder when directors assess themselves through past contribution 

Long-serving directors can provide institutional memory, sector expertise and valuable continuity. 

Those benefits are real. 

Yet board composition should reflect future challenges rather than reward past contribution indefinitely. 

The UK Corporate Governance Code 2024 expects boards to think carefully about composition, independence, refreshment and succession. 

A useful succession conversation therefore asks: 

• Which capabilities will matter during the next three to five years? 

• Which strategic choices are approaching? 

• Where is current board experience strongest? 

• Where is it weakest? 

• What will technology change? 

• Which markets are becoming more important? 

• Does the board need additional transaction or transformation experience? 

The strongest boards refresh before outsiders force the conversation. 

9. Independence should mean intellectual independence, not simply meeting a definition 

Formal independence criteria matter. 

They cannot guarantee independent judgement. 

A director may satisfy every technical independence test yet rarely challenge management. 

Another may have relevant industry connections while demonstrating considerable intellectual independence. 

Boards facing shareholder pressure should therefore examine the quality of challenge rather than simply the composition chart. 

Do directors: 

• Question assumptions? 

• Ask for alternatives? 

• Challenge capital allocation? 

• Push back on optimism? 

• Reopen decisions when evidence changes? 

• Request additional information? 

• Disagree constructively? 

• Examine management incentives? 

A board that agrees too easily can become strategically fragile. 

Good governance does not require permanent conflict. 

It does require enough constructive tension to prevent consensus becoming complacency. 

Read More: Board Evaluation & Assessment 

10. Board evaluation should test whether uncomfortable questions are actually being asked 

Many board evaluations examine: 

• Meeting effectiveness 

• Board papers 

• Committee structures 

• Skills 

• Relationships 

• Chair performance 

Those areas matter. 

Activism suggests another useful question: 

Is the board challenging the same issues an informed external investor would challenge? 

That means examining whether directors have debated: 

• Strategic alternatives 

• Underperforming businesses 

• Capital allocation 

• Balance-sheet structure 

• M&A 

• Cost base 

• Management performance 

• Portfolio complexity 

• Board composition 

• Investor confidence 

If an external campaign introduces questions that have never appeared meaningfully on the board agenda, directors should ask why. 

That is the value of independent evaluation. 

It can expose blind spots while the board still has time to address them privately. 

11. Activism often reveals an explanation gap before it reveals a strategy gap 

Boards naturally focus on whether their strategy is correct. 

Investors also focus on whether they understand it. 

The two are connected but distinct. 

A board may have a credible long-term plan yet fail to explain: 

• How value will be created 

• When results should become visible 

• Why current investment is necessary 

• Why alternatives were rejected 

• Which milestones will prove progress 

• What would cause the strategy to change 

When these answers remain vague, shareholders are left to construct their own narrative. 

That narrative may be less generous. 

The governance lesson is important. 

Strategy communication is not public relations. It is part of accountability. 

Investors need enough information to judge whether capital remains in responsible hands. 

12. Governance reporting should explain decisions, not simply governance structures 

The annual report is one of the board’s most important accountability documents. 

Yet governance sections can still devote considerable space to: 

• Committee membership 

• Meeting numbers 

• Attendance 

• Responsibilities 

• Governance processes 

Those disclosures are useful. 

They are not enough. 

Readers also need to understand: 

• What the board focused on 

• Which alternatives were examined 

• What changed 

• How investors influenced thinking 

• Which governance weaknesses were identified 

• How board evaluation affected composition 

• Why significant capital decisions were made 

The FRC’s 2024 Code places increased emphasis on governance outcomes and meaningful explanation. 

A company under pressure should therefore ask whether its reporting makes board judgement visible. 

If the strategy matters enough to defend publicly, the reasoning behind it should already be understandable. 

Read More: Annual Report Services 

13. The Company Secretary becomes especially important before activism becomes public 

Shareholder activism is often framed as an issue for the Chair, CEO, investor relations team and external advisers. 

The Company Secretary has an important role as well. 

The function sits close to several critical information flows: 

• Shareholder engagement 

• Board agendas 

• Board papers 

• Director concerns 

• Committee activity 

• Board actions 

• Governance reporting 

• Succession 

• Board evaluation 

That position allows the Company Secretary to notice patterns. 

Repeated shareholder concerns. 

Actions that remain unresolved. 

Strategic questions that disappear from future agendas. 

Information that reaches the board late. 

Governance weaknesses raised through evaluation but never fully addressed. 

Used properly, the Company Secretary can become an institutional early-warning mechanism. 

That does not mean taking sides between management and shareholders. 

It means ensuring the board receives the information necessary to exercise independent judgement. 

The Company Secretary should help prevent disagreement from becoming invisible until it becomes public. 

Explore: CoSec Hub 

14. Minutes matter when somebody later asks whether the board genuinely challenged management 

When a strategy comes under pressure, governance records become important. 

Did the board consider alternatives? 

Were assumptions challenged? 

Did directors examine downside scenarios? 

Were conflicts addressed? 

What information supported the decision? 

The purpose of minutes is not to construct a defensive record after the fact. 

Nor should minutes become transcripts designed around future litigation. 

They should accurately reflect the substance of governance that actually occurred. 

Strong minutes provide evidence of: 

• Material matters considered 

• Appropriate challenge 

• Significant alternatives 

• Decisions 

• Conflicts 

• Agreed actions 

If the board conducted a rigorous strategic debate, the institutional record should make that visible. 

Where minutes show only that the strategy was noted or approved, much of the board’s governance work becomes invisible. 

Read More: Minute Taking Solutions 

15. Activist preparedness should not become activist paranoia 

There is a danger at the other extreme. 

Boards can become so focused on activism defence that they distort governance. 

Every shareholder concern becomes a threat. 

Investor engagement becomes intelligence gathering. 

Capital decisions are shaped around avoiding criticism rather than creating sustainable value. 

That would be a mistake. 

The purpose of activism preparedness is not to defeat hypothetical activists. 

It is to create a board that does not need an activist to tell it where serious questions exist. 

Preparedness therefore means: 

• Understanding shareholders 

• Challenging strategy 

• Reviewing capital allocation 

• Maintaining appropriate board skills 

• Monitoring performance 

• Examining alternatives 

• Ensuring credible succession 

• Communicating clearly 

These are not activist-defence practices. 

They are simply good governance. 

16. A board should distinguish between disagreement and loss of confidence 

Shareholders will disagree with boards. 

That is normal. 

The warning sign appears when disagreement evolves into doubt about the board’s willingness or ability to reconsider its position. 

Several indicators may suggest confidence is weakening: 

• The same issue appears repeatedly in investor meetings 

• Major shareholders request direct Chair engagement 

• Votes against directors increase 

• Investors publicly question capital allocation 

• Shareholders seek external strategic reviews 

• Governance concerns become linked with performance concerns 

• Investors call for board refreshment 

• Engagement moves from private dialogue to public campaigning 

No single signal proves a crisis. 

Together, they deserve attention. 

The UK Corporate Governance Code provides a formal example of this principle. Where 20% or more of votes are cast against a board recommendation, companies should explain how they intend to consult shareholders, report on the views received and ultimately describe how that feedback affected board decisions. 

The principle extends beyond the threshold. 

Listening matters most before opposition becomes measurable. 

17. The best activist defence is a board that behaves as though a thoughtful activist is already in the room 

This does not mean adopting an activist mindset blindly. 

It means maintaining intellectual discipline. 

Before approving strategy, ask: 

What is the strongest argument against this plan? 

Before retaining an underperforming asset: 

Why does the company remain the best owner? 

Before approving another acquisition: 

Would shareholders receive greater value if we returned the capital? 

Before renewing a director: 

What capability does the board need next? 

Before dismissing investor criticism: 

What evidence would make us change our mind? 

Before defending complexity: 

What value does that complexity create? 

These are uncomfortable questions. 

That is precisely why boards should ask them. 

What activists increasingly target 

Current activism data provides a useful board-preparedness framework. 

The board should not wait until an activist raises these questions. 

They belong on the board agenda already. 

Ten questions boards should ask before an activist does 

1. Where has shareholder confidence weakened during the past 12 months? 

2. Which parts of our strategy are hardest to explain convincingly? 

3. Which businesses or assets would an outsider argue we should not own? 

4. When did the board last examine credible strategic alternatives? 

5. Can we demonstrate disciplined capital allocation? 

6. Does the board have the capabilities required for the company’s next strategic phase? 

7. Which concerns appear repeatedly in shareholder engagement? 

8. Can we show how those concerns reached board decision making? 

9. Would our governance reporting persuade a sceptical investor? 

10. What would we change if we were analysing the company from the outside? 

A board that cannot answer several of these confidently should not wait for a campaign. 

The governance conversation has already become necessary. 

Could your board withstand an external challenge to its judgement? 

Activism is ultimately a test of board confidence, capability and explanation. 

That makes board health relevant long before an investor asks for representation. 

The Lumorus Board Health Check provides boards, Chairs and governance leaders with a practical starting point for examining whether the underlying governance architecture is strong enough to withstand greater scrutiny. 

It can help prompt questions around: 

• Board composition 

• Skills 

• Information quality 

• Challenge 

• Decision making 

• Accountability 

• Committee effectiveness 

• Strategic oversight 

• Governance maturity 

The Board Health Check does not predict activism, nor is it designed as activist-defence advice. 

Its value lies in something more fundamental. 

External pressure is easier to manage when the board has already examined its own weaknesses honestly. 

Where the diagnostic identifies deeper issues, organisations can then consider a more detailed Governance Review, Board Evaluation & Assessment or Board Skills Audit. 

Assess your board: Take the Lumorus Board Health Check 

The Lumorus View 

When an activist demands a board seat, the most important question is not whether the board can defeat the request. It is whether directors can explain why the request is unnecessary. 

That requires more than procedural authority. 

The board needs a credible strategy. 

Its capital allocation should withstand comparison with alternatives. 

Directors need the skills appropriate to the company’s current challenges. 

Shareholders should understand the board’s reasoning even when they disagree with it. 

Most importantly, the board should already have asked itself the difficult questions the activist is about to make public. 

Activists do not possess a monopoly on insight. 

They can be wrong. 

Their proposed solutions may carry risks, misunderstand the business or place too much weight on short-term valuation. 

Boards should challenge those assumptions rigorously. 

However, directors weaken their position when the principal response is defensiveness. 

The stronger response is evidence. 

We considered that alternative. 

Here is why we rejected it. 

We understand the valuation concern. 

Here is what needs to change. 

We reviewed capital allocation. 

Here is why this remains the best use of capital. 

We evaluated board capability. 

Here is how succession is addressing the gaps. 

That is institutional confidence. 

A board earns the right to defend its strategy by demonstrating that it has challenged that strategy harder than its critics have. 

The Bottom Line 

Shareholder activism is not disappearing. 

The Lazard H1 2026 review recorded the busiest first half on record globally, with capital allocation, M&A, board change and strategy all featuring prominently in campaigns. The UK represented more than half of European activity during the period. 

Meanwhile, Skadden’s European activism research points to increasingly assertive investor tactics and continuing attention to board composition, returns and governance. 

Boards should not interpret those trends as a reason to become defensive. 

They should become more self-critical. 

Strong activism preparedness means being able to explain: 

• Strategy 

• Capital allocation 

• Portfolio structure 

• Board composition 

• Performance 

• Governance 

• Shareholder engagement 

• Strategic alternatives 

The Company Secretary has an important role because those issues intersect directly with board information, decision records, shareholder engagement, succession and governance evidence. 

The objective is not to make activism impossible. 

That would be unrealistic. 

It is to ensure that an external challenge does not reveal a question the board should have confronted much earlier. 

The real warning sign is not that an activist wants a seat at the table. It is discovering that the board has no persuasive answer to the question that brought them there. 

Continue Exploring 

• Test the health of your board before external scrutiny does: Lumorus Board Health Check 

• Examine whether your governance architecture remains fit for purpose: Governance Review 

• Assess board effectiveness and quality of challenge: Board Evaluation & Assessment 

• Test whether board capabilities match the next strategic phase: 

• Board Skills Audit 

• Strengthen board and shareholder governance: Board & Shareholder Meetings 

• Improve governance structures and board support: Corporate Governance Support 

• Strengthen the record of board decisions and challenge: Minute Taking Solutions 

• Build stronger governance reporting: Annual Report Services 

How Lumorus Supports Boards Under Greater Shareholder Scrutiny 

Lumorus helps boards and governance leaders examine whether the structures behind corporate decision making remain appropriate as investor expectations, regulation and strategic complexity increase. 

Our approach begins with the board rather than the campaign. 

We help organisations examine: 

• Board effectiveness 

• Composition and skills 

• Governance architecture 

• Decision processes 

• Information flows 

• Shareholder engagement 

• Accountability 

• Board records 

• Governance reporting 

• Company Secretary capability 

For boards seeking an initial diagnostic, the Lumorus Board Health Check provides a practical starting point. 

Where deeper analysis is required, Lumorus can support organisations through Governance Reviews, Board Evaluations and Board Skills Audits. 

The aim is not to tell boards how to defeat shareholders. 

It is to help directors ensure that their own governance, strategy oversight and accountability can withstand serious challenge. 

Could your board explain its most contested strategic decision to a sceptical shareholder today, including the alternatives considered and why the chosen course remains superior? 

If that answer would be difficult, the conversation should begin before somebody else forces it. 

Take the Lumorus Board Health Check or explore Lumorus to strengthen board effectiveness and governance resilience. 

Lumorus: Better Business, Built on Purpose. 

Sources 

• Lazard: Review of Shareholder Activism, H1 2026 – Analysis of 184 global activist campaigns during the first half of 2026, including trends in board change, strategy, M&A, capital allocation and UK activism. 

• Lazard: Annual Review of Shareholder Activism 2025 – Global analysis showing a third consecutive record year for activism, with board change and capital allocation among leading campaign themes. 

• Skadden and Mergermarket: Activist Investing in Europe 2026 – Research into European activist behaviour, board and management demands, shareholder returns, governance concerns and increasing activity from non-local investors. 

• Financial Reporting Council: UK Corporate Governance Code 2024 – The current UK governance framework covering board leadership, shareholder engagement, composition, independence, succession and accountability. 

• Financial Reporting Council: Corporate Governance Code Guidance – FRC guidance on constructive shareholder relations, the role of the Chair, board information, stakeholder dialogue and effective decision making. 

• Financial Reporting Council: UK Corporate Governance Code, Provision 4 – Requirements concerning shareholder consultation and reporting where 20% or more of votes are cast against a board recommendation. 

• PwC: Preparing for a Changing Disclosure Landscape, What the 2026 Proxy Season Can Tell Us – Analysis highlighting year-round shareholder engagement as an early-warning mechanism and the importance of pressure-testing strategy, performance, capital allocation and governance vulnerabilities.